The British medicine producer has followed several companies which have dropped inclusion policies following pressure from US President Donald Trump ... chief executive Emma Walmsley to £21.6 ...

Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues. After raising ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...